JPRN-UMIN000008406已完成未知
A double-blind cross-over study comparing the effects of single doses of fexofenadine, olopatadine, ketotifen fumarate and placebo on sedation in healthy Japanese subjects - A study comparing the effects of anti histamine on sedation
Clinical trial Center,Kitasato University East Hospital0 个研究点目标入组 16 人开始时间: 2012年7月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 40years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •-Any anaphylaxis with fexofenadine, olopatadine or ketotifen fumarate. -Any renal or hepatic disease requiring treatment. -Any convulsive disease or disease requiring treatment. -Any hereditary problem of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. -QT prolongation over 460 ms. -Use of any medicine or health product that contains Saint John's wort within 7 days before dosing. - Intake of fruit juice containing grapefruit juice or orange juice within 7 days before dosing. - Participation in any other clinical reseach in the past 3 months. - Donating over 200 ml of blood within the past 1 month or over 400 ml of blood within the past 3 months. - Poorly controlled arterial hypertension (Systolic blood pressure >160mmHg and/or diastolic blood pressure >100mmHg) - Positive HIV antibody, VDRL(quality), HBs antigen or HCV antibody. - Positive drug screening. - Any condition that, in the opinion of the investigator, would make the subject unsuitable for participation in the study.
研究者
相似试验
进行中（未招募）
不适用
A Randomized, Double-Blind Study to Compare the Efficacy of Treatment withDenosumab versus Alendronate Sodium in Postmenopausal Women with LowBone Mineral DensityPostmenopausal osteoporosis /osteopeniaEUCTR2005-005081-37-DEAmgen Inc1,100
进行中（未招募）
不适用
A Randomized, Double-Blind Study to Compare the Efficacy of Treatment withDenosumab versus Alendronate Sodium in Postmenopausal Women with LowBone Mineral DensityPostmenopausal osteoporosis /osteopeniaEUCTR2005-005081-37-BEAmgen Inc1,100
进行中（未招募）
不适用
A Randomized, Double-Blind Study to Compare the Efficacy of Treatment withDenosumab versus Alendronate Sodium in Postmenopausal Women with LowBone Mineral DensityPostmenopausal osteoporosis /osteopeniaEUCTR2005-005081-37-DKAmgen Inc1,100
进行中（未招募）
1 期
A Randomized, Double-Blind Study to Compare the Efficacy of Treatment with Denosumab versus Alendronate Sodium in Postmenopausal Women with Low Bone Mineral DensityPostmenopausal osteoporosis /osteopeniaEUCTR2005-005081-37-GBAmgen Inc1,100
进行中（未招募）
不适用
Efficacy and safety of trazodone OAD and venlafaxine XR in the treatment of Major Depressive DisorderMedDRA version: 14.1Level: HLGTClassification code 10012375Term: Depressed mood disorders and disturbancesSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 14.1Level: SOCClassification code 10037175Term: Psychiatric disordersSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 14.1Level: HLTClassification code 10012401Term: Depressive disordersSystem Organ Class: 10037175 - Psychiatric disordersMajor Depressive DisorderEUCTR2011-005878-37-ITANGELINI360